Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    0.00 (0.00%)
Bid:
521.00
Ask:
524.00
Spread: 3.00 (0.576%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

20 Oct 2025 07:00

RNS Number : 8983D
Galliford Try Holdings PLC
20 October 2025
 

GALLIFORD TRY APPOINTED TO MAJOR NEW £3 BILLION AFFORDABLE HOMES FRAMEWORK

Galliford Try's Building business has been appointed to a £3 billion affordable homes framework by major Registered Provider (RP), The Hyde Group.

The business has been confirmed on all seven lots of the new Main Contractor framework across the East, South and London regions the 120,000-home RP operates in. The framework runs for five years and is targeting building 1,500 homes per year during that period.

Bill Hocking, Chief Executive of Galliford Try, commented: "Delivering low to mid-rise apartment blocks for the affordable homes market is a key part of our Sustainable Growth Strategy to 2030, and we are delighted to have achieved a place on this major framework with a housing association that has a significant track record in development. We look forward to working with Hyde to bring forward the much-needed high-quality homes that their customers deserve."

 

Galliford Try

 

Bill Hocking, Chief Executive 01895 855001

Kris Hampson, Chief Financial Officer

Kevin Corbett, General Counsel & Company Secretary

 

Notes to editors 

 

Galliford Try Holdings plc is a leading UK construction group listed on the London Stock Exchange, and a member of the FTSE 250. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFZMMGDNVGKZM
Date   Source Headline
6th Jul 20233:30 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20232:32 pmRNSTotal Voting Rights
21st Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:00 amRNSSettlement Agreed and Special Dividend
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 202311:00 amRNSConfirmation of Directorate Change
1st Jun 202310:15 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
18th May 20233:30 pmRNSHolding(s) in Company
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20233:00 pmRNSAppointment of Non Executive Director
17th May 20237:00 amRNSTransaction in Own Shares
11th May 20237:10 amRNSContract
10th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 202311:00 amRNSTotal Voting Rights
2nd May 20237:10 amRNSContract
2nd May 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20232:00 pmRNSDirector/PDMR Shareholding
13th Apr 20237:10 amRNSContract
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:00 amRNSTotal Voting Rights
31st Mar 20233:00 pmRNSConfirmation of Director Change
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:05 amRNSContract
29th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20239:37 amRNSCorrection: Transaction in Own Shares
24th Mar 20237:00 amRNSContract
23rd Mar 20237:00 amRNSContract
22nd Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 202310:30 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSContract
8th Mar 20237:10 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSHalf-year Report
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSContract
1st Mar 20239:35 amRNSTotal Voting Rights
27th Feb 20234:00 pmRNSHolding(s) in Company
24th Feb 202310:42 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.